All lymph nodes (unless an individual without any autoimmune or genetic disease, including cancer, lives under sterile conditions) are exposed to varying concentrations of different types of antigens. Thus, all non-neoplastic lymph nodes show varying degrees of reactive changes. These changes may be particularly marked in younger individuals, but may be observed in all ages. [1] [2] [3] The most important consideration in assessing a reactive lymph node is in its distinction from a neoplasm, mainly the various types of malignant lymphoma. In a minority of circumstances, the specific pattern of reaction may strongly suggest a specific etiology. For these two reasons, it is helpful to try to characterize reactive lymphadenopathies by patterns of reaction. Each pattern suggests specific types of malignant lymphoma that may be considered in the differential diagnosis, and each pattern suggests a general type of immune response, which raises certain disease classes in the differential diagnosis. We have found it useful to separate benign lymphadenopathies into the following seven categories:
1. Follicular 2. Paracortical/interfollicular 3. Sinus 4. Extensive necrosis 5. Granulomatous 6. Connective tissue framework 7. Deposition of interstitial substance One should also keep in mind that these patterns are never pure. Thus, reactive follicular hyperplasia usually has a component of paracortical hyperplasia, and sometimes one cannot even determine the dominant process. Nonetheless, from a differential diagnostic standpoint, it is useful to try to assess the dominant process. In this review, we will briefly review reactive follicular hyperplasia, with its differential diagnosis from follicular lymphoma, discussing IgG4-related sclerosing disease-associated lymphadenopathy as an example; reactive paracortical/interfollicular hyperplasia, discussing acute infectious mononucleosis as an example; and lymph nodes with extensive necrosis, discussing Kikuchi histiocytic necrotizing lymphadenitis as an example. Due to the limitations of this review, the other patterns will not be discussed.
Reactive follicular hyperplasia
Follicular hyperplasia is the most common pattern of reactive lymphadenopathy. It is usually associated with varying degrees of paracortical and/or sinus hyperplasia. It is particularly commonly seen in children and young adults, but may be encountered in all ages, including the very elderly. 4 Clinically, the lymphadenopathy is usually localized, but may be generalized. The cervical and axillary areas are most frequently involved, corresponding to the lymph-node groups most likely to drain antigens. Table 1 lists the most common diseases that give rise to histologic findings that may suggest the specific etiology of the follicular hyperplasia.
Atypical follicular hyperplasia
Atypical follicular hyperplasia is a descriptive term that describes a diagnostic dilemma rather than a specific diagnosis. Table 2 lists the main histologic differential diagnostic features between reactive follicular hyperplasia and follicular lymphoma. 5, 6 Please note that there is no one pathognomonic histologic feature. Therefore, one should rather rely upon a constellation of characteristics. Even the history can be helpful. The older the patient, the more likely the diagnosis is follicular lymphoma. Generalized lymphadenopathy is also more commonly seen with follicular lymphoma than reactive follicular hyperplasia. The one single most useful histologic feature is the density of follicles (follicle:interfollicular ratio) on low magnification. The more the follicles and the less the interfollicular areas, the more likely is the diagnosis of malignant lymphoma. In fact, a complete back-to-back arrangement of the follicles is seen in over 75% of cases of follicular lymphoma, while only seen in the most florid cases of reactive follicular hyperplasia. The greatest exception to this rule is when there are areas of diffuse nodal effacement, another feature favoring follicular lymphoma. These areas are usually focal, but are mass forming, and not distributed evenly around individual follicles. Lymph nodes with floridly reactive follicles may also occasionally show one or more of the following features: extension of the process outside the capsule, the presence of follicles throughout the node, predominance of centroblasts, and absent or greatly diminished mantle zones (Figure 1 ). These latter two features are particularly common in florid reactive follicular hyperplasia occurring in childhood as well as in cases associated with human immunodeficiency virus infection.
Immunohistochemical and other special studies may be very helpful in distinguishing reactive follicular hyperplasia and follicular lymphoma. These studies are summarized in Table 3 . Determination of bcl-2 expression in paraffin sections is the single most useful ancillary study, being consistently negative in reactive follicular hyperplasia, but positive in about 90% of cases of follicular lymphoma. 7 However, one can occasionally see large numbers of bcl-2 þ T-helper/inducer cells in cases of reactive follicular hyperplasia. 7 Comparison with CD3 stains and the observation that the bcl-2 þ cells are not centroblasts can help with this pitfall. Another pitfall is to mistake bcl-2 þ primary follicles for bcl-2 positivity in follicular lymphoma. Comparison with other stains, including a germinal center marker such as bcl-6 or CD10 or a marker of primary follicle lymphoid cells such as IgD may be helpful ( Figure 2 ). The types of follicular lymphoma that are most likely to be bcl-2 negative include grade 3 follicular lymphoma and follicular lymphoma arising in children. In situ involvement by follicular lymphoma may show only scattered bcl-2 þ cells, but the bcl-2 expression in this process is usually much stronger than the adjacent bcl-2 staining of either T-helper/inducer cells or adjacent B-mantle cells. Ki-67 stains may also be useful; not only are higher numbers of germinal center cells usually positive in reactive follicular hyperplasia than follicular lymphoma, the stain may demonstrate a pattern of polarity that may not have been evident on routine light microscopy. 8 Immunoglobulin protein studies are helpful in only a minority of cases, as is also the case for in situ hybridization studies for mRNA expression; however, they are often most helpful in grade 3 follicular lymphoma. 9 Rarely, florid reactive follicular hyperplasia, particularly in younger individuals, may show light chain restriction, particularly in flow cytometry studies. 10,11 These cases are rare and may even show monoclonal populations by molecular analysis.
Gene rearrangement studies may be helpful in the distinction of reactive vs neoplastic follicular proliferations, although one must keep in mind that PCR studies for immunoglobulin heavy and light chains may be falsely negative in up to 20% of cases of follicular lymphoma due to the process of somatic hypermutation, and that 'pseudoclonal' immunoglobulin gene rearrangements may be rarely seen in reactive follicular hyperplasia, with the incidence depending on the primers used, the number of B cells in the specimen, as well as the size of the aliquot (particularly when o50 ng is analyzed). Similarly, although the detection of a t(14;18) (BCL2 gene rearrangement) usually provides strong support for a diagnosis of lymphoma, 12 up to 10% of cases of follicular lymphoma (usually grade 3) may be negative, and the t(14;18), as well as other cytogenetic abnormalities, may be rarely observed in reactive follicular hyperplasia. 13 Figure 2 At left is a bcl-2 stain. The bcl-2-positive primary follicle may easily be mistaken for follicular lymphoma. At right is a serial section stained for bcl-6. The bcl-6 negativity is consistent with a primary folllicle.
IgG4-related sclerosing diseaseassociated lymphadenopathy
IgG4-related sclerosing disease is a recently recognized clinicopathologic syndrome, probably autoimmune in nature, characterized by tumor-like enlargement of one or more exocrine glands or extranodal sites, raised serum IgG4 levels, and a lymphoplasmacytic infiltration associated with sclerosis, with increased numbers of IgG4-secreting plasma cells. IgG4 is the least common subclass of IgG, constituting only about 3-6% of the entire IgG fraction. It is unique in its inability to bind C1q (and hence cannot activate the classical complement pathway). IgG4-related sclerosing disease involves numerous sites, particularly the pancreas (autoimmune pancreatitis/lymphoplasmacytic sclerosing pancreatitis), the biliary tract (lymphoplasmacytic cholecystitis; sclerosing cholangitis), submandibular gland (chronic sclerosing sialadenitis/Kuttner tumor), lacrimal gland (chronic sclerosing dacryoadenitis), liver ('inflammatory pseudotumor'), lung (interstitial pneumonia, 'inflammatory pseudotumor'), breast (IgG4-related sclerosing mastitis), kidney (tubulointerstitial nephritis; membranous glomerulopathy), soft tissues (retroperitoneal and mediastinal fibrosis), and other sites.
Lymph nodes may also be affected, and may show a predominantly follicular or paracortical pattern. [14] [15] [16] Clinically, there is a marked male predominance in some series, affecting mostly middleaged to elderly individuals. The most common sites include mediastinal, intraabdominal, and axillary lymph nodes. Involved lymph nodes are usually not very large, commonly about 1-2 cm. Exocrine and other extranodal lesions may precede, follow, or present together with the lymphadenopathy. Patients may have anemia (sometimes Coombs positive), increased ESR or C-reactive protein, elevated globulin and IgG levels, or the presence of autoantibodies, while LDH is normal or only slightly elevated. Morphologically, several patterns of involvement have been described. Some cases resemble the plasma cell/multicentric types of Castleman disease. In most cases, there is reactive follicular hyperplasia, often associated with an interfollicular plasmacytosis. Intrafollicular plasma cells may be seen in some cases, and progressive transformation of germinal centers, sometimes with a rim of epithelioid histiocytes, may be present in one-half of these cases (Figure 3) . In a subset of cases, there is preferential paracortical expansion, always including plasma cells and sometimes having eosinophils. Focal areas of fibrosis may be present. The diagnosis may be confirmed by the identification of an elevated serum IgG4 level and increased numbers of IgG4 þ plasma cells on immunostaining (IgG4 þ cells 450/hpf and an IgG4 þ /IgG þ cell ratio of 440%) (Figure 4 ). It must be kept in mind that other diseases besides IgGrelated sclerosing disease can give rise to increased numbers of IgG4 cells in lymph nodes. In particular, the possibility of a parasitic infestation and an allergic condition should be ruled out clinically and pathologically.
Reactive paracortical interfollicular hyperplasia
Reactive paracortical/interfollicular hyperplasia is a relatively common lymph-node pattern. The process is virtually never that of reactive paracortical hyperplasia without any participation by other compartments, particularly reactive follicular hyperplasia, but also reactive sinus hyperplasia. However, this section will consider those diseases in which reactive paracortical hyperplasia represents the dominant histologic pattern. This is important to consider from a differential diagnostic viewpoint as well as possibly suggesting a specific diagnosis.
A specific etiology cannot be determined for the large majority of cases of reactive paracortical hyperplasia. Similarly to reactive follicular hyperplasia, reactive paracortical hyperplasia occurs in all age groups, but is more common in young patients. Table 4 lists the most common diseases that give rise to histologic findings that may suggest the specific etiology of the paracortical hyperplasia.
In reactive paracortical hyperplasia, one sees expansion of the paracortical areas by a mixed infiltrate, often imparting a mottled appearance. There is usually a concomitant reactive follicular hyperplasia. At high magnification, the paracortical areas usually show a mixture of small and large lymphoid cells, but without significant cytologic atypia (the latter manifested by highly irregular or hyperchromatic nuclei). There are often immunoblasts, which are usually relatively evenly dispersed, and large numbers of plasma cells, eosinophils, and histiocytes are typical ( Figure 5 ). Vascularity is often increased, usually with prominent high endothelial venules. Occasionally, reactive paracortical hyperplasia may take the appearance of small to large nodules of small (and sometimes irregular) T cells admixed with dendritic cells, so-called nodular paracortical T-cell hyperplasia, found in association with a wide variety of benign and malignant disorders. When associated with melanin pigment, and usually more diffuse throughout the lymph node, a diagnosis of dermatopathic lymphadenitis may be made.
Atypical paracortical/interfollicular hyperplasia
Similarly to atypical follicular hyperplasia, atypical paracortical hyperplasia is a descriptive term that describes a diagnostic dilemma rather than a specific diagnosis. The major and most important differential diagnosis for reactive paracortical hyperplasia is peripheral T-cell lymphoma. 17 Histologically, obliteration or marked diminution of the B-cell cortical region would favor a diagnosis of T-cell lymphoma, as the cortical region usually also undergoes hyperplasia in most cases of reactive paracortical hyperplasia. The most important criterion is the presence of cytologically atypical cells in T-cell lymphoma. In reactive paracortical hyperplasia, there is often an admixture of cell types, including immunoblasts, but a continuous spectrum of cytologic atypia among the lymphoid cells would favor a T-cell lymphoma. A diminution of the B-cell compartments (cortical and subcapsular areas) seen by immunohistochemical studies would favor a T-cell lymphoma. While peripheral T-cell lymphoma may contain B cells, including B immunoblasts, the greater the number of admixed B cells of both large and small size, the more likely the diagnosis of reactive paracortical hyperplasia. The demonstration of T-cell phenotypic abnormalities such as loss of one or more pan-T cell antigens or abnormal expression of antigens (such as loss of membrane expression of a pan-T-cell marker, of gain of CD10 or bcl-6) would favor a diagnosis of T-cell lymphoma. Finally, the molecular detection of clonal T-cell receptor gene rearrangements would provide strong evidence for a diagnosis of T-cell lymphoma.
Reactive paracortical hyperplasia and Hodgkin lymphoma may also be difficult to distinguish from one another. In the interfollicular variant of Hodgkin lymphoma, the Hodgkin cells are found in between hyperplastic follicles. Sometimes, areas that are more typical of Hodgkin lymphoma are seen elsewhere in the biopsy. Hodgkin cells tend to cluster in one area of the lymph node, are not usually associated with typical immunoblasts in a 'reactive milieu', and are usually found in their characteristic background. Careful cytologic evaluation of the large atypical cells, together with immunohistochemical 
Acute infectious mononucleosis
Most initial infections with Epstein-Barr virus (EBV) occur asymptomatically in children under the age of 5, even in western countries. Symptomatic acute infectious mononucleosis occurs in all age groups except childhood. Approximately, one-third of EBV infections occurring in adolescents is symptomatic, with a continuum of increasing percentage and severity of symptoms as initial infection occurs at older ages. The most common symptoms include sore throat, fever, and lymphadenopathy, particularly anterior or posterior cervical lymphadenopathy. However, many other lymph-node groups may be affected. Markedly enlarged tonsils are almost always present, splenomegaly is found in 50% of cases, and hepatomegaly occurs in about 10%. Hematologic examination usually reveals lymphocytosis, with at least 10% atypical lymphocytes (95% T cells). If the diagnosis is suspected clinically, then the diagnosis can be confirmed serologically, either by IgM monospot test or by more specific EBV antibody serologic studies. However, in cases that have come to biopsy, the diagnosis is almost always not considered clinically. Other diseases that may have a similar clinical and laboratory profile include cytomegalovirus or HHV-6 infection.
The earliest manifestation of acute infectious mononucleosis may be a prominent monocytoid B-cell proliferation, along with reactive follicular hyperplasia. However, soon after, there is an immunoblastic proliferation, which may be quite striking. [18] [19] [20] These cells typically have prominent nucleoli and abundant cytoplasm. They have a high mitotic rate and may form sheets, may be found in sinuses, and may be multinucleated, mimicking either non-Hodgkin lymphoma or Hodgkin lymphoma (Figure 6 ). There are usually abundant plasma cells, and there may be eosinophils or epithelioid histiocytes. Necrosis may be absent, focal or extensive. Follicles usually show striking reactive follicular hyperplasia, but this feature may be overshadowed by the paracortical hyperplasia.
Immunohistochemical studies are non-specific. The monocytoid cells in the sinuses mark as B cells, the reactive germinal centers are bcl-2 negative, and the immunoblasts are a mixture of T and B cells. One may see co-expression of CD43 and CD20 on the immunoblasts, a finding that does not equate to a diagnosis of lymphoma in this setting. Many of the immunoblasts may be CD30 þ , including sheets of cells, a finding that does not equate to a diagnosis of anaplastic large cell lymphoma in this setting; ALK staining is negative. The most useful studies are those for identifying EBV. Virtually all cases have varying number of EBV-latent membrane protein (LMP)-positive cells, usually immunoblasts. EBV encoded RNA (EBER) in situ hybridization labels many more EBV-positive cells, including numerous large and small cells in the paracortical areas, and scattered cells in the germinal centers and monocytoid B-cell areas, and is the method of choice for the identification of EBV in this setting (Figure 7) . 21 The differential diagnosis includes both nonHodgkin lymphoma and Hodgkin lymphoma. Misdiagnosis of acute infectious mononucleosis as Hodgkin or non-Hodgkin lymphoma is a common error in lymph-node pathology. Simply stated, one should not diagnose a diffuse large cell lymphoma in either the tonsil or cervical lymph nodes in a child or adolescent without first considering and ruling out a possible diagnosis of acute infectious mononucleosis! In situ hybridization using EBER probes is the most helpful ancillary study for the tissue diagnosis of acute infectious mononucleosis. In EBV-positive diffuse large B-cell lymphomas, the EBV is uniformly present in the large neoplastic cells, and absent or virtually absent in the small lymphocytes, while in infectious mononucleosis, the positive cells are a subset of both large and small lymphocytes. Gene rearrangement studies may also be of use, however, both immunoglobulin and T-cell receptor studies may show oligoclonal or occasionally monoclonal patterns of gene rearrangement. A diagnosis of Hodgkin lymphoma may be considered if one focuses too carefully on the high magnification appearance of the immunoblasts, but the overall context is not that of Hodgkin lymphoma, with a high mitotic rate and usually an accompanying florid reactive follicular hyperplasia. In situ hybridization may show EBV positivity in classical Hodgkin lymphoma (particularly in cases occurring in patients under the age of 21), but almost all the positive cells are large cells, and there are many fewer positive cells than seen in acute infectious mononucleosis, which has both large and small positive cells. In contrast to classical Hodgkin lymphoma, immunohistochemical studies do not show CD15 reactivity in the large cells in acute infectious mononucleosis, although many large cells may express CD30 and lack CD45 expression, similarly to classical Hodgkin lymphoma.
Benign lymphadenopathy with extensive necrosis
Any benign lymphadenopathy may at times show necrosis, either focal or extensive. However, some lymphadenopathies characteristically show extensive necrosis. 22 
Kikuchi histiocytic necrotizing lymphadenitis
Kikuchi histiocytic necrotizing lymphadenitis is an inflammatory disorder of unknown etiology. [23] [24] [25] [26] It most commonly affects young Asian women, although it may occur in both sexes and in all age groups and ethnicities. Patients most often present with isolated cervical lymphadenopathy, which may be tender, and of several months duration. They sometimes have a history of a fever with upper respiratory symptoms; less commonly, they may have systemic symptoms, such as malaise and weight loss. The prognosis is excellent, with resolution usually occurring with 1-4 months, although some patients may relapse. No convincing association with viruses has been found, and an autoimmune pathogenesis has been proposed, given that the similar histologic appearance seen in lymph nodes involved by systemic lupus erythematosis.
Grossly involved lymph nodes are usually only mildly enlarged. Histologically, three phases have been described. In the first phase, the proliferative phase, there are patchy areas of involvement, with adjacent areas showing a non-stimulated appearance or a non-specific reactive follicular and/or paracortical hyperplasia. In the areas of involvement, there is a proliferation of medium-to-large lymphoid cells, histiocytes, and plasmacytoid dendritic cells (Figure 8 ). Scattered small lymphocytes may be present, but do not dominate the histologic picture. The histiocytes have a bland chromatin pattern, but may have highly irregular nuclear outlines (eg, crescentic, twisted, or even signet-ring shaped nuclei). They often contain phagocytosed Figure 8 Kikuchi histiocytic necrotizing lymphadenitis, proliferative phase. This field, containing numerous macrophages, could be easily mistaken for a diffuse large cell lymphoma. Note the scattered karyorrhectic debris, which is a clue to the correct diagnosis. Figure 9 Kikuchi histiocytic necrotizing lymphadenitis, progressing toward the necrotic stage. There is more abundant karyorrhexis seen than in Figure 8 , with the beginning of fibrin deposition. cellular fragments. The plasmacytoid dendritic cells are hard to identify when present singly, but tend to cluster, particularly at the edges of the lesion. Neutrophils, eosinophils, and plasma cells are rare. There is usually no widespread necrosis at this stage, although single cell necrosis and karyorrhectic debris may be present and even prominent (Figure 9 ). In the second phase-the necrotic phase-focal to extensive areas of geographic necrosis are present. These areas show an eosinophilic appearance, often with admixed karyorrhectic debris. Once again, mature neutrophils are rare, and medium-to-large sized lymphoid cells and histiocytes are usually present at the margins of the necrosis. In the final phase, the resolution stage, large numbers of foamy macrophages may be seen. Immunohistochemical studies show a predominance of T cells and macrophages. Helper/inducer (CD3 þ / CD4 þ ) cells predominate in the early phase, while cytotoxic/suppressor (CD3 þ /CD8 þ ) cells predominate in the more commonly biopsied necrotic stage. Only scattered CD20 þ B immunoblasts are present. CD123 is a good marker for confirming the presence of plasmacytoid dendritic cells.
The typical clinical setting of Kikuchi necrotizing histiocytic lymphadenitis should be kept in mind in the differential diagnosis with non-Hodgkin lymphoma. The proliferative stage of the disease, in particular, may be easily mistaken for a diffuse large cell lymphoma, with its predominance of mediumto-large lymphoid cells, histiocytes, and plasmacytoid dendritic cells. The presence of abundant karyorrhectic debris should raise suspicion of necrotizing histiocytic lymphadenitis. Immunohistochemical studies showing few B cells will rule out the possibility of a B-cell lymphoma, and a predominance of CD8 þ cells, if found, is only seen in a minority of cases of peripheral T-cell lymphoma. The presence of focal necrosis raises the differential diagnosis with Hodgkin lymphoma, but the absence of morphologic and immunohistologic evidence of Hodgkin cells at the border of the necrosis would make this diagnosis unlikely. Granulomatous necrotizing lymphadenitis has greater numbers of neutrophils and epithelioid histiocytes, forming stellate microabscesses as opposed to patchy areas of necrosis, while non-suppurative granulomatous inflammation usually has well (or at least better) defined granulomas, which may show central caseation. Systemic lupus erythematosis may have additional features such as scattered plasma cells and, more rarely, hematoxylin bodies in sinuses that distinguish it from Kikuchi histiocytic necrotizing lymphadenitis, but at times may have an identical histologic appearance. For this reason, appropriate serologic and other studies should always be performed in all potential cases of Kikuchi histiocytic necrotizing lymphadenitis to rule out this possibility. Finally, Kawasaki disease can be distinguished by its clinical setting and greater extent of vascular changes.
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